Zimbabwe has rejected a major American health deal worth 367 million US dollars (£272m) spanning five years due to the United States' demand for sensitive biological samples.
This rejection came to light following a internal memorandum dated December was disclosed, which showed President Emmerson Mnangagwa felt the deal was "skewed".
A government representative later clarified that the United States was demanding access to health data for research and commercial purposes while was unwilling to share the benefits from any future medical innovations.
"We will now turn to the challenging and unfortunate process of scaling back our health assistance in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont in a statement.
The US Embassy noted the US had furnished over $1.9bn as health assistance to Zimbabwe during the past two decades.
A doctors' association in Zimbabwe has appealed for further dialogue to reach a deal suitable to both sides so the country's vital HIV treatment initiative can proceed.
Wider Context
Zimbabwe's decision comes after a similar situation in neighbouring Kenya, where a high court suspended a similar health funding agreement following legal challenges were filed about the security of citizens' health data.
Since resuming office last year, US President Donald Trump has reduced foreign aid and shut down the US Agency for International Development (USAID).
USAID had administered aid for the US government, but Trump claimed its spending was "wasteful" and his administration was pursuing direct bilateral deals to enhance transparency and responsibility.
Based on statements, Sixteen African countries have to date signed similar agreements, representing over $18.3bn in committed funds.
Specifics of the Rejected Agreement
The funds for Zimbabwe would have supported "tackling HIV/Aids, TB, malaria, maternal and child health, and disease outbreak preparedness.
"We believe this collaboration could have provided immense benefits for the people of Zimbabwe, particularly the 1.2 million men, women and children presently on antiretroviral therapy via American-funded programmes," Tremont added.
However, official spokesman Nick Mangwana argued the proposed deal was "unequal".
"The proposal required Zimbabwe to surrender its genetic material and health information over an extended period, without any corresponding assurance of access to any medical innovations – such as new medicines or tests – that might be developed from that shared data," Mangwana explained.
"Effectively, our nation would supply the raw materials for scientific discovery without any assurance that the final treatments would be accessible to our citizens should a new disease outbreak emerge."
Sovereignty and Global Health
He also noted that the American exit from the World Health Organization (WHO) and its pursuit of bilateral deals were upending structures already established through the international health agency.
Mangwana cited its Pathogen Access and Benefit Sharing framework created to deal with potential global health emergencies.
"This mechanism is designed to guarantee that when a country provides its samples, the resulting advantages – such as medicines and cures – are shared equitably, not commercialised exclusively by those with the capability to create them."
Zimbabwe's reservations over the US deal "must not be interpreted as opposition to America," he added.
"We welcome ongoing dialogue with our American counterparts on how subsequent collaboration could be arranged in a manner that honours the independence and dignity of each country."
Health Experts Response
The Zimbabwe College of Public Health Physicians (ZCPHP) said it acknowledged the government's concerns, but recommended that talks must proceed given that a large portion of the country's Aids initiatives depended on foreign aid.
"If specific concerns exist, such as those relating to data governance or agreement terms, these can often be addressed via technical clarification and mutually agreed protections," it added.
This impasse highlights the complex challenges between accepting much-needed international aid and protecting local interests in an ever more data-driven world.